Activists praised the president's request for an additional $267 for the Ending the HIV Epidemic initiative but said it falls short of what they'd like to see.
An experimental drug taken weekly, or even monthly, has shown efficacy in preventing HIV.
The federal government, which has filed a competing suit against Gilead, had sought dismissal of the pharma company's suit.
The pandemic is causing innumerable problems, including challenges to HIV prevention.
UnitedHealthcare will cease Descovy coverage in September, but generic Truvada will be covered at no out-of-pocket cost.
A global HIV prevention study was stopped early after ViiV Healthcare’s cabotegravir shows to be more effective than the current daily treatment.
After interviewing over 1,500 gay and bisexual men, researchers say those on PrEP are less worried about contracting HIV.
